scispace - formally typeset
D

Daniel Prieto-Alhambra

Researcher at University of Oxford

Publications -  438
Citations -  11189

Daniel Prieto-Alhambra is an academic researcher from University of Oxford. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 45, co-authored 345 publications receiving 7269 citations. Previous affiliations of Daniel Prieto-Alhambra include Erasmus University Medical Center & Mount Vernon Hospital.

Papers
More filters
Journal ArticleDOI

Temporal Trends and Geographical Variation in Dupuytren Disease Surgery in England: A Population-Based Cohort Study.

TL;DR: There was a striking 3.6-fold variation in the rates of primary DD surgery among National Health Service CCGs in England place of residence and this significant variation in DD surgical treatment in England suggests a need for the development of standardized surgical practice across all CCGs and National health Service hospitals.
Journal ArticleDOI

Sat0591 a clinical tool for automated prediction of hip and major osteoporotic fractures using electronic medical records data: the epic study

TL;DR: A fracture prediction tool that leverages patient data as routinely available in primary care computerized records and can be installed in electronic primary care records systems for automated risk calculations at the population level is developed and validated.
Journal ArticleDOI

078 Association between oral corticosteroid prescribing patterns and appropriate fracture preventive care: UK and Ontario population-based cohort studies

TL;DR: In this article , the authors conducted a nationwide cohort study using routinely collected UK general practice data and found that those prescribed OCS continuously were at higher risk of major osteoporotic fractures (adjusted HR 1.44 95%CI 1.28-1.62).
Posted ContentDOI

Contribution of genetics and lifestyle to the risk of major cardiovascular and thromboembolic complications following COVID-19

TL;DR: It is demonstrated that population genetics and lifestyle considerably influence cardiovascular complications following COVID-19, with implications for future personalised thromboprophylaxis and healthy lifestyle campaigns to offset the elevated cardiovascular disease burden imposed by the ongoing pandemic.